The management of suicidal patients with recurrent mood disorder involves a comprehensive clinical and psychosocial evaluation. This will determine treatment strategies including: acute care; continuation and prophylactic therapy with drugs; psychological treatment (including education to patients and their families). Risk factors for suicide and parasuicide are evaluated including: demography; psychosocial factors; personality characteristics; clinical characteristics; evaluation of preceding clinical state; seasonality. Treatment of the underlying illness is the most powerful method of preventing suicide. Reference will be made to the recent National Institute of Mental Health Collaborative Studies on the value of pharmacotherapy and psychotherapy in the long-term management of mood disorders.
Abou-Saleh M.T. (1988) How useful is a dexamethasone suppression test?Curr Opinions Psychiatr1: 60-65
2.
Abou-Saleh M.T., Coppen A.J. (1986) Who responds to prophylactic lithium?J Affect Disorders10: 115-125
3.
Abou-Saleh M.T., Coppen A.J. (1988) Continuation therapy with antidepressants after electroconvulsive therapy (editorial). Convulsive Ther4: 263-268
4.
Abou-Saleh M.T., Coppen A. (1989a) Serum and red blood cell folate in depression . Acta Psychiatr Scand80: 78-82
5.
Abou-Saleh M.T., Coppen A. (1989b) The efficiency of low-dose lithium: clinical psychological and biological correlates. J Psychol Res23: 157-162
6.
Abou-Saleh M.T., Coppen A.J. (1990) Predictors of long-term outcome of mood disorder on prophylactic lithium. Lithium1: 27-35
7.
Angst J., Frey R., Lohmeyer B., Zerbin-Rudin E. (1980) Bipolar manic-depressive psychoses: Results of a genetic investigation. Hum Genet55: 237-254
8.
Asberg M., Thoren P., Traskman L., Bertilsson L., Ringberger V. (1976) Serotonin depression: a biochemical subgroup within the affective disorders?Science191: 478-480
9.
Beck A.T., Schuyler D., Herman J. (1974) Development of suicidal intent scales. In Beck A T, Resnick H L P, Lettieri D J (eds), The prediction of suicide. Charles Press, Bowie, MD, pp. 45-56
10.
Bourne H.R., Bunney W.E., Colburn R.W., Davis J.M., Shaw D.M., Coppen A.J. (1968) Noradrenaline, 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in hind brains of suicidal patients. Lancet2: 805-808
11.
Brent D., Perper J.A., Allman C. (1987) Alcohol, firearms, and suicide among youth: temporal trends in Allegheny County, PA, 1960-1983. J Am Med Assoc257: 3369-3372
12.
Brent D.A., Kupfer D.J., Bromet E.J., Dew M.A. (1988) The assessment and treatment of patients at risk for suicide. Rev Psychiatr7: 353-385
13.
Cohen J. (1986) Statistical approaches to suicidal risk factor analysis. Ann N Y Acad Sci487: 34-41
14.
Coppen A., Abou-Saleh M.T. (1983) Lithium in the prophylaxis of unipolar depression: a review. J R Soc Med76: 297-301
15.
Coppen A., Chaudhry S., Swade C. (1986) Folic acid enhances lithium prophylaxis. J Affect Disorders10: 9-13
16.
Coryell W., Keller M., Endicott J., Andreasen N., Clayton P., Hirschfeld R. (1989) Bipolar II illness: course and outcome over a five-year period. Psychol Med19: 129-141
17.
Doogan D.P., Caillard V. (1988) Sertraline in the prevention of relapse in major depresson. Psychopharmacology96 (Suppl. I): 271
18.
Dunner D.L., Dwyer T., Fieve R. (1976) Depressive symptoms in patients with unipolar and bipolar affective disorder. Comp Psychiatr17: 447-451
19.
Fowler R.C., Tsuang M.T., Kronfol Z. (1979) Communication of suicidal intent and suicide in unipolar depression. J Affect Disorders1: 219-225
20.
Frank E., Kupfer D.J., Perel J.M., Cornes C., Jarett D.B., Mallinger A.G., Thase M.E., McEachran A.B., Grochocinski V.J. (1990) Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatr47: 1100-1105
21.
Glen A I M, Johnson A.L., Shepherd M. (1984) Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trial . Psychol Med14: 37-50
22.
Goodwin F.K., Jamison K.R. (1990) The clinical management of suicidal patients. In Goodwin F K, Jamison K R (eds), Clinical management of suicidal patients in manic depressive illness. Oxford University Press, New York, pp.769-779
23.
Hirsch S.R., Walsh C., Draper R. (1983) The concept and efficacy of the treatment of parasuicide . Br J Clin Pharmacol15: 189S-194S
24.
Klerman G.L. (1990) Treatment of recurrent unipolar major depressive disorder. Arch Gen Psychiatr47: 1158-1162
25.
Kreitman N., Smith P., Tan E. ( 1970) Attempted suicide as language: an empirical study. Br J Psychiatr116: 465-473
26.
Lee A.S., Murray R.M. (1988) The long-term outcome of Maudsley depressives. Br J Psychiatr153: 741-751
27.
Liberman R.P., Eckman T. (1981) Behaviour therapy vs insight-oriented therapy for repeated suicide attempters. Arch Gen Psychiatr38: 1126-1130
28.
Mann J.J., Stanley M., McBride P.A., McEwen B.S. (1986) Increased serotonin2 adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatr43: 954-959
29.
Mathews W., Barabas G. (1981) Suicide and epilepsy: a review of the literature . Psychosomatics22: 515-524
30.
Miles C. (1977) Conditions predisposing to suicide: a review. J Nerv Ment Dis164: 231-246
31.
Mindham R.H., Howland C., Shepherd M. (1973) An evaluation of continuation therapy with tricyclic antidepressants illness. Psychol Med5: 5-17
32.
Montgomery S.A., Montgomery D.B., Ravi S.J., Ray D.H., Shaw P.J. (1979) Maintenance therapy in repeat suicidal behaviour: a placebo controlled trial. In Proceedings of the 10th International Congress for Suicide Prevention, Ottawa, Ontario, June 1979, pp. 227-229
33.
Montgomery S.A., Ray D., Montgomery D.B. (1983) The prevention of recurrent suicidal acts. Br J Clin Pharmacol15:183S-188S
34.
Montgomery S.A., Dufour H., Brion S., Gailledreau J., Laqueille X., Ferrey G., Moron P., Parant-Lucena N., Singer L., Danion J.M., Beuzen J.N., Pierredon M.A. (1988) The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatr153 (Suppl. 3): 69-76
35.
Motto J. (1976) Suicide prevention for high-risk persons who refuse treatment. Suicide Life Threat Behav6: 223-230
36.
Paykel E.S. (1986) Stress and life events. National Institutes of Mental Health Conference on Youth Suicide, Bethesda, MD, May 1986
37.
Pokorny A.D. (1966) A follow-up of 618 suicidal patients. Arch Gen Psychiatr14: 1109-1116
38.
Pokorny A.D. (1983) Prediction of suicide in psychiatric patients. Arch Gen Psychiatr40: 249-257
39.
Prien R.F., Kupfer D.J., Mansky P.A., Small J.G., Tuason V.B., Boss C.B., Johnson W.E. (1984) Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders: a report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen PsychiatrB41: B1096-B1104
40.
Quitkin F.M. (1985) The importance of dosage in prescribing antidepressants . Br J Psychiatr147: 593-597
41.
Reynolds E.H., Chanarin I., Milner G., Matthews O.M. (1966) Anticonvulsant therapy, folic acid and vitamin B12 metabolism and mental symptoms. Epilepsia7: 261-270
42.
Roy A. ( 1982) Risk factors for suicide in psychiatric patients. Arch Gen Psychiatr39: 1089-1095
43.
Schou M. (1979) Lithium as a prophylactic agent in unipolar affective illness: comparison with cyclic antidepressants. Arch Gen Psychiatr36: 849-851
44.
Schulsinger R., Kety S., Rosenthal D., Wender P.H. (1979) A family study of suicide. In Schou M, Stromgren E (eds), Origins, prevention, and treatment of affective disorders. Academic Press, London, pp. 277-287
45.
Shaw D.M., Camps F.E., Eccleston E.G. (1967) 5-Hydroxytryptamine in the hind brain of depressive suicides. Br J Psychiatr113: 1407-1411
46.
van Praag H.M., Kahn R.S., Asnis M.G., Wetzler S., Brown S.L., Bleich A., Korn M.L. (1987) Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. J Affect Disorders13: 1-8
47.
Weissman M., Paykel E.S. (1974) The depressed woman: a study of social relationship . University of Chicago Press, Chicago, Illinois
48.
Weissman M.M., Prusoff B.A., Klerman G.L. (1978) Personality and the prediction of long term outcome of depression. Am J Psychiatr135: 797-800
